[1] |
Wu Qian, Wang Wei, Zhang Yu, Chen Songhua, Chen Bin.
Construction of an evaluation indicator system for Zero Tuberculosis Community in Zhejiang Province
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 331-337.
|
[2] |
Wang Xueyu, Wang Yujin, Chu Naihui, Kang Wanli, Nie Wenjuan.
A preliminary study on the enhanced in vivo exposure of sudapyridine in Mycobacterium abscessus-infected rats with the co-administration of clofazimine or clarithromycin
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 150-157.
|
[3] |
Li Xuelian, Zhang Hongyan, Wang Jun, Wang Qingfeng, Ma Liping, Chu Naihui, Nie Wenjuan.
Safety of extended delamanid use in drug-resistant tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 164-168.
|
[4] |
Yan Guangxuan, Wang Xueyu, Wang Yujin, Lan Tinglong, Nie Wenjuan.
Diagnostic value of using metagenomic second-generation sequencing on suspected osteoarticular tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 175-180.
|
[5] |
Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei.
Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60.
|
[6] |
Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei.
Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062.
|
[7] |
Wang Biao, Liu Yuhong, Sun Yuxian, Zhang Lijie, Li Zhili, Shu Wei.
Investigation and analysis of laboratory diagnostic capabilities in tuberculosis-designated hospitals in China
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1089-1097.
|
[8] |
Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong.
Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896.
|
[9] |
Jia Hongyan, Fan Jun, Sun Qi, Song Ruixue, Du Boping, Dong Jing, Wang Yingchao, Xing Aiying, Zhu Chuanzhi, Li Zihui, Pan Liping.
Comparison of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold In-Tube assay in auxiliary diagnosis of osteoarticular tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 648-653.
|
[10] |
Wang Liyan, Zhou Hui, Wu Qian, Hao Xiaogang, Lu Bingxin, Chen Bin.
Evaluation of the implementation effect of the “Zero Burden” strategy for diagnosis and treatment of pulmonary tuberculosis in Longyou County, Zhejiang Province
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 418-423.
|
[11] |
Li Ting, Liu Shuang, Wang Danxia, Lu Jia, Cheng Qianqian, Chen Chuang, He Jin’ge, Zhang Linglin, Xia Yong, Li Jing, Zhang Shu, Gao Wenfeng, Xia Lan.
Evaluation of health economics of implementation of tuberculosis prevention and control program in Sichuan Province from 2011 to 2020
[J]. Chinese Journal of Antituberculosis, 2024, 46(3): 333-339.
|
[12] |
Li Xuelian, Jing Wei, Wang Qingfeng, Chu Naihui, Nie Wenjuan.
An all-oral shortened regimen containing new drugs to treat MDR/rifampicin-resistant tuberculosis: three case reports and literature review
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1327-1334.
|
[13] |
Hu Qiang, Jin Linyuan, Zhou Xiaohui, Zhang Qianrong, Deng Yuhang, Tang Xianpeng, Zhou Haiyi, Zhang Min.
The value of ultrasound examination in the diagnosis and treatment evaluation of chest tuberculosis in children
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1350-1355.
|
[14] |
Ming Wenhua, Ma Tingting, Wang Hongtian, Wang Xueyan.
Aspirin-exacerbated respiratory diseases: pathogenesis and treatment strategies
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1400-1405.
|
[15] |
Sha Wei.
Significance and challenges of the implementation of PAN-TB treatment strategy for tuberculosis prevention and control
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1188-1192.
|